Combined Resection vs. Separated Resection After Mobilization of Splenic Vein During Distal Pancreatectomy
NCT02871804 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 304
Last updated 2016-08-18
Summary
Eligible patients will be centrally randomized to either Arm A (resection of the splenic vein after isolation from the pancreatic parenchyma) or Arm B (co-resection of the vein together with the pancreas).
Conditions
- Pancreatic Neoplasms
Interventions
- PROCEDURE
-
combined resection of the splenic vein
combined resection of the splenic vein with the pancreatic parenchyma before ligation and division during distal pancreatectomy using mechanical staplers.
- PROCEDURE
-
separated resection of the splenic vein
separated resection of the splenic vein from the pancreatic parenchyma before ligation and division during distal pancreatectomy using mechanical staplers.
Sponsors & Collaborators
-
Wakayama Medical University
lead OTHER
Principal Investigators
-
Hiroki Yamaue, MD, PhD · Wakayama Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2019-08-31
- Completion
- 2020-02-29
Countries
- Japan
Study Locations
More Related Trials
-
Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma.
NCT07148830 ·Status: RECRUITING ·Phase: NA
-
A Novel Surgical Strategy to Reduce Major Complications in Patients With Necrotizing Pancreatitis
NCT06241586 ·Status: COMPLETED
-
Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients
NCT03278015 ·Status: UNKNOWN ·Phase: PHASE2
-
Oncological Safety of Spleen Preservation in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)
NCT07157605 ·Status: RECRUITING
-
Conventional Partial Pancreatoduodenectomy Versus an Extended Pancreatoduodenectomy for Pancreatic Head Cancers
NCT06703905 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.
NCT04835064 ·Status: UNKNOWN ·Phase: PHASE3
-
Phase I Study of Neoadjuvant Chemotherapy for Patients With Borderline Resectable Pancreatic Cancer.
NCT02506803 ·Status: UNKNOWN ·Phase: PHASE1
-
Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy
NCT03398291 ·Status: UNKNOWN ·Phase: PHASE3
-
Failure to Adjuvant Therapy After Pancreatic Resection for Pancreatic Cancer
NCT03788382 ·Status: COMPLETED
-
Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases
NCT06980792 ·Status: COMPLETED
-
Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer
NCT02459652 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas
NCT03779464 ·Status: UNKNOWN ·Phase: PHASE2
-
Effects of Epidural Block on the Prognosis in Patients With Pancreatic Cancer Undergoing Distal Pancreatectomy
NCT03659292 ·Status: UNKNOWN ·Phase: NA
-
A Phase III Study of Pancreatic Cancer
NCT00994721 ·Status: COMPLETED
-
Resection in Pancreatic Cancer With Minimal Metastatic Disease or Venous Infiltration Trial at Technische Universität München
NCT00855634 ·Status: TERMINATED ·Phase: NA
-
A Study to Evaluate Splenectomy on Debridement for Acute Necrotizing Pancreatitis With Pancreatic Sinistral Portal Hypertension
NCT07080697 ·Status: RECRUITING ·Phase: NA
-
Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarcinoma
NCT02928081 ·Status: UNKNOWN ·Phase: NA
-
S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer
NCT02131493 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Patients With Borderline Resectable Pancreatic Cancer
NCT03199144 ·Status: WITHDRAWN ·Phase: PHASE2
-
Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer
NCT07081360 ·Status: RECRUITING ·Phase: PHASE3
-
Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection
NCT02023021 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
NCT01240304 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer
NCT02481635 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Bilateral Thoracoscopic Splanchnicectomy for Pain Relief in Patients With Unresectable Pancreatic Cancer
NCT03117556 ·Status: WITHDRAWN ·Phase: NA
-
Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas
NCT00003049 ·Status: COMPLETED ·Phase: PHASE3